HERSHBERG ROBERT — SEC insider filings
SEC reporting owner CIK 1274139. 57 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers the 50 most recent of 57 filings on record, filed 2020-11-18 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 37 legs across 19 filings — 288,268 shares, $3,445,020 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 93.
- Largest priced transaction: sale of 100,000 shares @ $4.96 ($496,000) in AtaiBeckley Inc., filed 2026-07-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Director | 15 | — | 13 legs · 118,632 sh · $2,167,465 | 27 |
| AtaiBeckley Inc. (ATAI) | Director | 3 | — | 1 leg · 100,000 sh · $496,000 | 10 |
| NanoString Technologies Inc (NSTG) | Director | 7 | — | 18 legs · 5,832 sh · $419,445 | 15 |
| HilleVax, Inc. (HLVX) | President and CEO, Director | 4 | — | 3 legs · 38,132 sh · $221,822 | 5 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | 11 | — | 1 leg · 25,000 sh · $125,000 | 22 |
| FATE THERAPEUTICS INC (FATE) | Director | 4 | — | 1 leg · 672 sh · $15,288 | 5 |
| Atai Beckley N.V. (ATAI) | Director | 1 | — | — | 4 |
| Silverback Therapeutics, Inc. (SBTX) | Director | 3 | — | — | 3 |
| DANAHER CORP /DE/ (DHR) | Director | 2 | — | — | 2 |
Insider filings — HERSHBERG ROBERT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | DANAHER CORP /DE/ (DHR) | Grant/award (A): 282 @ $0 · Grant/award (A): 663 (derivative) @ $0 | EDGAR |
| 2026-10-16 | 3 | DANAHER CORP /DE/ (DHR) | Holdings only — no transactions reported | EDGAR |
| 2026-10-07 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 25,000 @ $2.22 · Sale (S): 25,000 @ $5 · Option exercise (M): 25,000 (derivative) @ $2.22 | EDGAR |
| 2026-09-11 | 4 | AtaiBeckley Inc. (ATAI) | Disposition to issuer (D): 48,858 (derivative) · Disposition to issuer (D): 404,869 (derivative) · Disposition to issuer (D): 62,394 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-08-20 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 15,000 @ $24.39 · Sale (S): 15,664 @ $24.41 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-07-09 | 4 | AtaiBeckley Inc. (ATAI) | Option exercise (M): 48,858 @ $1.35 · Option exercise (M): 51,142 @ $1.35 · Sale (S): 100,000 @ $4.96 · Option exercise (M): 48,858 (derivative) @ $0 · Option exercise (M): 51,142 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 88,424 @ $0 | EDGAR |
| 2026-06-08 | 4 | AtaiBeckley Inc. (ATAI) | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 15,625 @ $0 | EDGAR |
| 2025-12-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 22,968 @ $16 | EDGAR |
| 2025-11-06 | 4 | Atai Beckley N.V. (ATAI) | Grant/award (A): 456,011 (derivative) @ $0 · Grant/award (A): 97,716 (derivative) @ $0 · Grant/award (A): 62,394 (derivative) @ $0 · Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | HilleVax, Inc. (HLVX) | Code (U): 1,101,498 | EDGAR |
| 2025-06-23 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 22,016 @ $0 · Grant/award (A): 44,031 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 53,000 @ $7.59 | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 15,394 @ $0 · Grant/award (A): 23,726 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | HilleVax, Inc. (HLVX) | Sale (S): 14,634 @ $1.89 · Sale (S): 11,901 @ $1.76 | EDGAR |
| 2024-06-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 31,328 @ $0 · Grant/award (A): 48,044 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | HilleVax, Inc. (HLVX) | Sale (S): 11,597 @ $14.93 · Grant/award (A): 174,202 @ $0 · Grant/award (A): 226,885 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 12,612 @ $0 · Grant/award (A): 25,224 (derivative) @ $0 | EDGAR |
| 2023-06-07 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 14,775 @ $0 · Grant/award (A): 23,329 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | HilleVax, Inc. (HLVX) | Grant/award (A): 187,966 @ $0 · Grant/award (A): 381,950 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 53,000 @ $0.45 · Option exercise (M): 53,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 18,145 @ $0 · Grant/award (A): 36,290 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 8,650 @ $0 · Grant/award (A): 11,893 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Silverback Therapeutics, Inc. (SBTX) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | FATE THERAPEUTICS INC (FATE) | Sale (S): 672 @ $22.75 | EDGAR |
| 2022-04-18 | 4 | NanoString Technologies Inc (NSTG) | Option exercise (M): 3,306 · Option exercise (M): 3,306 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 6,689 @ $0 · Grant/award (A): 16,722 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 693 @ $0 | EDGAR |
| 2021-10-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 572 @ $0 | EDGAR |
| 2021-09-21 | 4 | Silverback Therapeutics, Inc. (SBTX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 347 @ $0 | EDGAR |
| 2021-06-17 | 4 | NanoString Technologies Inc (NSTG) | Option exercise (M): 5,520 · Option exercise (M): 5,520 (derivative) @ $0 · Grant/award (A): 3,890 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 2,681 @ $0 · Grant/award (A): 4,334 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 6,250 @ $0 · Conversion (C): 6,250 @ $0 · Conversion (C): 12,500 (derivative) @ $0 · Conversion (C): 12,500 (derivative) @ $0 · Conversion (C): 525,000 (derivative) @ $0 · Conversion (C): 525,000 (derivative) @ $0 | EDGAR |
| 2021-04-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-04-19 | 4 | NanoString Technologies Inc (NSTG) | Option exercise (M): 144 @ $14.71 · Sale (S): 7 @ $71.75 · Sale (S): 19 @ $72.87 · Sale (S): 118 @ $74.20 · Option exercise (M): 144 (derivative) @ $14.71 | EDGAR |
| 2021-03-17 | 4 | NanoString Technologies Inc (NSTG) | Option exercise (M): 1,500 @ $11.20 · Sale (S): 4 @ $63.58 · Sale (S): 282 @ $66.03 · Sale (S): 1,214 @ $67.16 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 2,000 @ $0.45 · Sale (S): 2,000 @ $44.56 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 2,000 @ $0.45 · Sale (S): 2,000 @ $44.56 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | NanoString Technologies Inc (NSTG) | Option exercise (M): 1,188 @ $11.20 · Sale (S): 318 @ $78.40 · Sale (S): 323 @ $79.53 · Sale (S): 159 @ $80.55 · Sale (S): 156 @ $81.79 · Sale (S): 163 @ $82.83 · +2 more | EDGAR |
| 2021-02-17 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 1,504 @ $0 · Option exercise (M): 2,000 @ $0.45 · Sale (S): 2,000 @ $65.45 · Grant/award (A): 3,759 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 2,000 @ $0.45 · Sale (S): 1,378 @ $66.34 · Sale (S): 622 @ $67.05 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2021-01-19 | 4 | NanoString Technologies Inc (NSTG) | Option exercise (M): 1,500 @ $11.20 · Sale (S): 709 @ $71.77 · Sale (S): 410 @ $72.91 · Sale (S): 291 @ $73.66 · Sale (S): 90 @ $74.55 · Option exercise (M): 1,500 (derivative) @ $11.20 | EDGAR |
| 2020-12-16 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 2,000 @ $0.45 · Sale (S): 1,759 @ $55.78 · Sale (S): 241 @ $57.01 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | NanoString Technologies Inc (NSTG) | Option exercise (M): 1,500 @ $11.20 · Sale (S): 688 @ $68.68 · Sale (S): 812 @ $69.88 · Option exercise (M): 1,500 (derivative) @ $11.20 | EDGAR |
| 2020-12-07 | 4 | Silverback Therapeutics, Inc. (SBTX) | Grant/award (A): 73,251 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 2,000 @ $0.45 · Sale (S): 1,777 @ $47.60 · Sale (S): 223 @ $48.41 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1274139 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs